Molecular markers, molecular-targeted therapies and taxanes: how to integrate the progress into clinical research and practice for the management of head and neck cancers.
Awada
Ahmad
A
Lalami
Yassine
Y
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000235:genetics; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000188:drug therapy*; D016503:Drug Delivery Systems; D019317:Evidence-Based Medicine; D006258:Head and Neck Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008495:Medical Oncology / Q000639:trends; D009367:Neoplasm Staging; D043823:Taxoids / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D043823:Taxoids